Plain-English translation of NCT04743791 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a newer asthma medication, helps your body clear mucus from your airways better than a placebo (a dummy injection). Researchers want to understand if this medication not only controls asthma symptoms but also improves how your lungs naturally clean themselves. You would receive either the medication or placebo for 12 weeks to see if there's a difference.
Many people with moderate to severe asthma struggle with mucus buildup in their airways, even with current treatments. This study aims to find out whether this medication can improve your lungs' natural ability to clear mucus, which could lead to better breathing and fewer asthma flare-ups.
You likely qualify if…
You likely don't qualify if…
You would visit the research center at the start and receive either two injections of the medication (or placebo) as a loading dose. After that, you would give yourself one injection every two weeks at home for 12 weeks. The study team would measure how well your airways clear mucus before and after treatment to see if there's any difference between the medication group and the placebo group.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States